SCHEMBL26696271

SCHEMBL26696271

CON(C)C(=O)CCC1CCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 5/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 2/20 0.37
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
HSD11B1 P28845 1/20 0.35
KDM5A P29375 2/20 0.34
KDM4C Q9H3R0 2/20 0.34
PHF8 Q9UPP1 2/20 0.34
KDM2A Q9Y2K7 2/20 0.34
ATM Q13315 1/20 0.34
KDM4E B2RXH2 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25062674 0.96 ALDH1A1 (0.42) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL10154212 0.95 ALDH1A1 (0.44) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL17064819 0.92 MEN1 (0.35) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL31673968 0.84 KDM4E (0.36) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL8070099 0.84 HTR4 (0.40)
SCHEMBL18438801 0.81 ALOX5 (0.34) KMT2AALDH1A1HPGDL3MBTL1KDM4E
SCHEMBL14734853 0.80 NPC1 (0.42) MEN1KMT2AALDH1A1NPC1RAB9A
SCHEMBL5077904 0.77 ALDH1A1 (0.46) MEN1KMT2AALDH1A1HPGD
SCHEMBL27406252 0.77 ALDH1A1 (0.46) MEN1KMT2AALDH1A1HPGD
SCHEMBL7500572 0.77 EPHX2 (0.37) KMT2AALDH1A1HPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339952-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2023-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339952-A1 MACROCYCLIC HETEROCYCLES AND USES THEREOF HRAS, KRAS, TP53 MEN1 596/4885KMT2A 3278/4885ALDH1A1 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.